1,986
Views
12
CrossRef citations to date
0
Altmetric
Editorial

Toward minimally disruptive management of symptomatic endometriosis: reducing low-value care and the burden of treatment

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1-4 | Received 12 Sep 2017, Accepted 28 Nov 2017, Published online: 06 Dec 2017

References

  • Gylfason JT, Kristjansson KA, Sverrisdottir G, et al. Pelvic endometriosis diagnosed in an entire nation over 20 years. Am J Epidemiol. 2010;172:237–243.
  • Soliman AM, Yang H, Du EX, et al. The direct and indirect costs associated with endometriosis: a systematic literature review. Hum Reprod. 2016;31:712–722.
  • Leyland N, Casper R, Laberge P, et al. SOGC. Endometriosis: diagnosis and management. J Obstet Gynecol Can. 2010;32:S1–32.
  • American College of Obstetricians and Gynecologists. Practice bulletin no. 114: management of endometriosis. Obstet Gynecol. 2010;116:223–236.
  • Practice Committee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis: a committee opinion. Fertil Steril. 2014;101:927–935.
  • Dunselman GA, Vermeulen N, Becker C, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29:400–412.
  • Vercellini P, Giudice LC, Evers JL, et al. Reducing low-value care in endometriosis between limited evidence and unresolved issues: a proposal. Hum Reprod. 2015;30:1996–2004.
  • Vercellini P, Facchin F, Buggio L, et al. Management of endometriosis: toward value-based, cost-effective, affordable care. J Obstet Gynaecol Can. 2017 Oct 5. pii: S1701-2163(17)30684-9. [Epub ahead of print] DOI:10.1016/j.jogc.2017.07.011.
  • Guo S-W. Recurrence of endometriosis and its control. Hum Reprod Update. 2009;15:441–461.
  • Koga K, Takamura M, Fujii T, et al. Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis. Fertil Steril. 2015;104:793–801.
  • Vercellini P, Bracco B, Mosconi P, et al. Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study. Fertil Steril. 2016;105:734–43.e3.
  • National Institute for Health and Care Excellence. Endometriosis: diagnosis and management (NICE guideline 73). 2017. [ cited 2017 Sep 9]. Available from: https://www.nice.org.uk/Guidance/NG73/evidence
  • Nisenblat V, Bossuyt PM, Farquhar C, et al. Imaging modalities for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016;2:CD009591.
  • Guerriero S, Condous G, Van den Bosch T, et al. Systematic approach to sonographic evaluation of the pelvis in women with suspected endometriosis, including terms, definitions and measurements: a consensus opinion from the International Deep Endometriosis Analysis (IDEA) group. Ultrasound Obstet Gynecol. 2016;48:318–332.
  • Vercellini P, Buggio L, Somigliana E. The role of medical therapy in the management of deep rectovaginal endometriosis. Fertil Steril. 2017;108:913–930.
  • American Association of Gynecologic Laparoscopists. AAGL position statement: robotic-assisted laparoscopic surgery in benign gynecology. J Minim Invasive Gynecol. 2013;20:2–9.
  • Berlanda N, Frattaruolo MP, Aimi G, et al. ‘Money for nothing’ The role of robotic assisted laparoscopy for the treatment of endometriosis. Reprod Biomed Online. 2017 May 30;35:435–444. pii: S1472-6483(17)30242-0. [Epub ahead of print]. DOI:10.1016/j.rbmo.2017.05.010.
  • American College of Obstetricians and Gynecologists. Ten things physicians and patients should question. Choosing Wisely. An initiative of the ABIM Foundation. Released March 14, 2016 (Items 6–10). Recommendation #6 revised August 24, 2016. [cited 2017 Sep 9]. Available from: http://www.choosingwisely.org/societies/american-college-of-obstetricians-and-gynecologists/
  • Mair FS, May CR. Thinking about the burden of treatment. BMJ. 2014;349:g6680.
  • Spencer-Bonilla G, Quiñones AR, Montori VM; International Minimally Disruptive Medicine Workgroup. Assessing the burden of treatment. J Gen Intern Med. 2017 Jul 11;32:1141–1145. DOI:10.1007/s11606-017-4117-8.
  • Paulden M. Recent amendments to NICE’s value-based assessment of health technologies: implicitly inequitable? Expert Rev Pharmacoecon Outcomes Res. 2017;17:239–242.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.